MedKoo Cat#: 555356 | Name: DDPM-2571 HCl

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DDPM-2571 is a highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties. DDPM-2571 was quickly distributed into the brain and was highly effective in the prevention of chemically-induced seizures (pentylenetetrazole and pilocarpine models) and 6-Hz convulsions. It demonstrated significant anxiolytic-like and antidepressant-like properties. DDPM-2571 had antinociceptive properties, both in the hot plate test and in the second phase of the formalin test.

Chemical Structure

DDPM-2571 HCl
DDPM-2571 HCl
CAS#1672672-26-2 (HCl)

Theoretical Analysis

MedKoo Cat#: 555356

Name: DDPM-2571 HCl

CAS#: 1672672-26-2 (HCl)

Chemical Formula: C21H21Cl3N2O3

Exact Mass:

Molecular Weight: 455.76

Elemental Analysis: C, 55.34; H, 4.64; Cl, 23.33; N, 6.15; O, 10.53

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
1672672-26-2 (HCl) 1672740-49-6 (free base)
Synonym
DDPM-2571; DDPM-2571; DDPM-2571;
IUPAC/Chemical Name
(E)-1-(2-((((2',4'-dichloro-[1,1'-biphenyl]-2-yl)methylene)amino)oxy)ethyl)-1,2,5,6-tetrahydropyridine-3-carboxylic acid hydrochloride
InChi Key
VSUXRUCFNHSXSI-KEJAMGHHSA-N
InChi Code
InChI=1S/C21H20Cl2N2O3.ClH/c22-17-7-8-19(20(23)12-17)18-6-2-1-4-15(18)13-24-28-11-10-25-9-3-5-16(14-25)21(26)27;/h1-2,4-8,12-13H,3,9-11,14H2,(H,26,27);1H/b24-13+;
SMILES Code
[H]Cl.OC(C1=CCCN(C1)CCO/N=C/C2=CC=CC=C2C3=C(Cl)C=C(Cl)C=C3)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Since GABAergic dysfunction underlies a variety of neurological and psychiatric disorders, numerous strategies leading to the augmentation of GABAergic neurotransmission have been introduced. One of them is the inhibition of GABA reuptake from the synaptic cleft mediated by four plasma membrane GABA transporters (GAT1-4). GAT1 which is exclusively expressed in the brain is an interesting target for centrally acting drugs.

Preparing Stock Solutions

The following data is based on the product molecular weight 455.76 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Sałat K, Podkowa A, Malikowska N, Kern F, Pabel J, Wojcieszak E, Kulig K, Wanner KT, Strach B, Wyska E. Novel, highly potent and in vivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties. Neuropharmacology. 2017 Feb;113(Pt A):331-342. doi: 10.1016/j.neuropharm.2016.10.019. Epub 2016 Oct 19. PubMed PMID: 27771379.